Effects of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effects of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials

Published:2017-09-27 Issue:2 Volume:20 Page:458-462
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Zhao Yumo¹^ORCID,Xu Lubin¹,Tian Dongli¹,Xia Peng¹,Zheng Hua¹,Wang Li²,Chen Limeng¹

Affiliation:

1. Department of Nephrology, Peking Union Medical College HospitalChinese Academy of Medical Sciences, Peking Union Medical College Beijing China

2. Department of Epidemiology and Biostatistics, Institute of Basic Medical SciencesChinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13101

Reference21 articles.

1. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China;Wang J;Asia Pac J Clin Nutr,2013

2. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review

3. Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus

4. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug

5. Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12

3. Recent Developments in 1,2,3‐Triazole Based α‐Glucosidase Inhibitors: Design Strategies, Structure‐Activity Relationship and Mechanistic Insights;Chemistry & Biodiversity;2024-08-22

4. Managing Gout in Patients with Metabolic Syndrome;Drugs & Aging;2024-07-27

5. Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin;JAMA Internal Medicine;2024-06-01